image

The best stocks to buy since 1993

Latest issue now available

HeiQ - Buys probiotic and prebiotic platform technologies

April 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • HEIQ
  • Price:
  • 200p
HeiQ has acquired 51% of Chrisal for €7.5m (€5m cash plus 1.1m shares). Chrisal develops probiotic formulations (live bacteria) and prebiotics (compounds that support good bacteria) to support a healthy microbiome on surfaces to which it is applied. It has developed 120 products eg. bio-based odor & stain control for carpet & footwear, microbial and viral protection for surfaces, anti-inflammatory effects in wound dressings,  algae and biofilm control in water as well as surface hygiene treatments for hospitals. In FY20, Chrisal grew sales by 60% to €5.5m and made operating profit of €1.6m. The deal also comes with a bottling facility in Belgium, which will support HeiQ's ambitions in functional texti ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe